Perspective · 10 Sep 2026
Conference abstractPublished 15 Oct 2013
Activation of an innate immune receptor, Nod1, accelerates atherogenesis in Apoe-/- mice
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Atherosclerosis is essentially a vascular inflammatory process in the presence of excess amount of lipid. We have recently reported that nucleotide-binding oligomerization domain (Nod)-1 ligands activated endothelial cells in vitro, and oral administration of a Nod1 ligand FK565 induced vascular inflammation in vivo. No studies, however, have proven the association between Nod1 and atherosclerosis in vivo. We orally administered FK565 to Apoe knockout (Apoe-/-) mice for 4 weeks intermittently, and performed quantification of atherosclerotic lesions in aortic roots and aortas, immunohistochemical analyses and microarray-based gene expression profiling of aortic roots. FK565 administration accelerated the development of atherosclerosis in Apoe-/- mice, and the effect was exclusively dependent on Nod1 in vascular cells of non-bone marrow origin by bone marrow transplantation experiments. Immunohistochemical studies revealed the increases in the accumulation of macrophages and CD3 T cells within the plaques in aortic roots. Gene expression analyses of aortic roots demonstrated a marked up-regulation of chemokine (C-C motif) ligand 5 (Ccl5) gene during early stage of atherogenesis, and the treatment with Ccl5 antagonist significantly inhibited the acceleration of atherosclerosis in FK565-administrated Apoe-/- mice. In addition, as compared with Apoe-/- mice, Apoe and Nod1 double knockout mice showed reduced development of atherosclerotic lesions from early stage as well as their delayed progression towards more advanced stages, and a significant reduction in Ccl5 mRNA levels at 9 weeks of age. We show that Nod1 signaling pathway in vascular cells of non-bone marrow origin contributes to the development and progression of atherosclerosis.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Toshiro Hara”
- BylineArticles whose byline prints “ShunsukeKanno”
- BylineArticles whose byline prints “Hisanori Nishio”
